Cardiac resynchronization therapy outcomes in patients under nonoptimal medical therapy.

Belén Alvarez-AlvarezJavier García-SearaJose L Martínez-SandeMoises Rodriguez-MañeroXesús A Fernández LópezLaila González MelchorRosa M Agra BermejoDiego Iglesias-AlvarezFrancisco Gude SampedroCarla Díaz-LouzaoJosé R González-Juanatey

Published in: Journal of arrhythmia (2018)

Basal OMT prior to CRT is not associated with better outcomes in terms of HF/death compared with no basal OMT. The subgroup of patients who achieved OMT at the 1-year follow-up exhibited a reduced risk of HF and death compared with patients who did not.

Keyphrases

cardiac resynchronization therapy
left ventricular
end stage renal disease
heart failure
ejection fraction
newly diagnosed
healthcare
prognostic factors
peritoneal dialysis
stem cells
acute heart failure
mesenchymal stem cells
patient reported outcomes
metabolic syndrome
cell therapy
open label
patient reported